免疫球蛋白:静注该药有致溶血反应风险

来源 :药物流行病学杂志 | 被引量 : 0次 | 上传用户:ZYXN
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
加拿大卫生部已警示医务人员,静注免疫球蛋白(IVIG)可发生溶血。此罕见的溶血反应与IVIG不良反应有关。IVIG的适应证为原发性及继发性免疫缺陷病的替换治疗,如特发的血小板减少性紫癜及慢性炎症髓鞘多发性神经疾病等。根据加拿大卫生部分析,所有溶血反应报告(溶血性贫 Health Canada has warned medical staff that intravenous immunoglobulin (IVIG) can hemolysis. This rare haemolytic reaction is associated with adverse effects of IVIG. IVIG indications for the replacement of primary and secondary immunodeficiency disease treatment, such as idiopathic thrombocytopenic purpura and chronic inflammatory myelin multiple neurological diseases. According to the Canadian Department of Health analysis, all hemolysis report (hemolytic poor
其他文献